BioPharmaDispatch Conference.
The Challenges of 2021 and Beyond
Sydney and 'Virtual'
17 May 2021
The Conference.
A Day of Powerful Talks
17 May 2021
Ivy Ballroom, Level 1, 320 George Street, Sydney
'Virtual'
About BPD.
What is the BPD conference?
The annual event of BioPharmaDispatch is a platform for the biopharmaceutical industry, its leaders, patient groups and key decision-makers to discuss issues impacting access to the latest healthcare technologies
A hybrid in-person and virtual event, the day features a range of speakers and panels. People can register to attend in person or virtually.
Organisations can also request 'bespoke' registration packages that provide a combination of in-person and virtual attendance. This includes a 'license' for unlimited virtual attendance. Please contact contact@dailydispatch.com.au for more information.
+300
Participants
12
Sessions
25
Speakers
Sponsors.
Conference Agenda.
7.30am - Patient group breakfast featuring Q&A with PBAC chair Professor Andrew Wilson and deputy chair Jo Watson
8.30am - Venue opens for full conference
8.55am - Conference welcome by host Rae Johnston
Official open
Health minister Greg Hunt
The pre-conditions for change
Will Delaat AM, former chair, Medicines Australia
David Learmonth, former deputy secretary, Department of Health
Achieving change
Jane Halton AO PSM, chair, CEPI and GBMA
The PBS and the law
Felicity McNeill PSM, Better Access Australia
Kelly Griffiths, Gadens
Making patient input to decision-making real
Catherine Holliday, Centre for Community-Driven Research
The regional and global industry perspective
Chris Hourigan, company group chairman, Asia Pacific, Janssen
The patient perspective
Annie Madden, Harm Reduction Australia
Melanie Funk, Eczema Support Australia
Nicole Cooper
The PBAC and change
Professor Andrew Wilson
The 'latest' chemotherapy review
David Slade, Slade Pharmacy
What is happening in New Zealand?
Dr Graeme Jarvis, CEO, Medicines New Zealand
Australia’s vaccines policy
Dr Brendan Shaw, Shawview Consulting
Jennifer Herz, Biointelect
The future direction of HTA in decision-making
Liz de Somer, MA
Dr Rachel David, Private Healthcare Australia
Ian Burgess, MTAA
The future community pharmacy
Trent Twomey, national president, Pharmacy Guild of Australia
Budget 2021-22 - the politics
Jody Fassina, Insight Strategy
Nick Campbell, NEXUS
The industry and the 2021-22 Budget
Michael Azrak, MSD
Ashraf Al-Ouf, Bayer
Australia and the COVID-19 vaccine
Liz Chatwin, AstraZeneca
Anne Harris, Pfizer
The opportunity of data
Peter Cronin, Prospection
The COVID-19 vaccine communication challenge
Melissa Millard, AstraZeneca
Helen Han, Pfizer
Joanne Cleary, Seqirus
Anne-Marie Sparrow, Cube
The opportunity of clinical trials in Australia
James McAdam, BMS
Zoe Armstrong, MSD
The industry, system stewardship and achieving change
Neil MacGregor, BMS
Christi Kelsey, GSK
Jeppe Theisen, Novo Nordisk